摘要
Qishan Formula (QSF) is mainly used to treat lung cancer and its side effects of radiotherapy and chemotherapy. Although the clinical efficacy of QSF has been recognized, its mechanism of action and active ingredients are still unclear. This study aims to explore the potential Q-Marker of QSF and reveal its anti-lung cancer mechanism. Firstly, the fingerprints of 10 batches of QSF were established, and the potential Q-markers were screened by chemometrics, then network pharmacology and molecular docking methods were used to explore its anti-lung cancer mechanism. Finally, the potential Q-markers were quantitatively by UPLC-QDA. The results showed that 48 common peaks were identified by the established fingerprint, and calycosin, ginsenoside Rg1, atractylenolide III, atractylenolide I and ginsenoside Rb1 were screened as potential Q-Markers of QSF by chemometrics. Network pharmacology and molecular docking found that the potential Q-Markers may regulate various signaling pathways through targets such as FOS, IL6, EGFR, ESR1, MAPK1, and MAPK3, and play a therapeutic role in lung cancer. Besides, the established UPLC-QDA can also perform quality control for Q-Markers of QSF. This study can provide academic ideas and lay a foundation for the comprehensive quality control and mechanism research of QSF and other compound preparation.
学科与关键词
- Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomicsGeng, Xue; Chi, Wencheng; Lin, Xiaoyue; Niu, Zeji; Jiang, Qinghui; Sui, Yutong; Jiang, Jiakang*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(13).
- Intervention effect of Qi-Yu-San-Long Decoction on Lewis lung carcinoma in C57BL/6 mice: Insights from UPLC–QTOF/MS-based metabolic profilingHuan Wu; Yang Chen; Qinglin Li; Yating Gao; Xingxing Zhang; Jiabing Tong; Zhiqiang Zhang; Jian Hu; Danyang Wang; Shijie Zeng; Zegeng LiJournal of Chromatography B, 2018, s 1102–1103: 23-33.
- A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico VerificationHu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 3436814.被引 1
